Premium
Skeletal muscle uncoupling protein‐3 restores upon intervention in the prediabetic and diabetic state: implications for diabetes pathogenesis?
Author(s) -
Mensink M.,
Hesselink M. K. C.,
Borghouts L. B.,
Keizer H.,
MoonenKornips E.,
Schaart G.,
Blaak E. E.,
Schrauwen P.
Publication year - 2007
Publication title -
diabetes, obesity and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.445
H-Index - 128
eISSN - 1463-1326
pISSN - 1462-8902
DOI - 10.1111/j.1463-1326.2006.00628.x
Subject(s) - ucp3 , skeletal muscle , uncoupling protein , medicine , endocrinology , impaired glucose tolerance , diabetes mellitus , type 2 diabetes , insulin resistance , pathogenesis , obesity , brown adipose tissue
Aim: Skeletal muscle uncoupling protein‐3 (UCP3) is reduced in type 2 diabetes, and in the pre‐diabetic condition of impaired glucose tolerance (IGT). Here we examined whether intervention programs known to improve insulin sensitivity are paralleled by an increase in skeletal muscle UCP3 protein levels. Methods: Skeletal muscle UCP3 protein content was measured before and after one year of an exercise intervention in muscle biopsies of eight diabetic subjects. In addition, UCP3 was measured in IGT subjects before and after 1 year of following a lifestyle‐intervention program or serving as control. Results: In the diabetic patients a significant increase of ∼75% in UCP3 protein was found after 1 year of exercise training (P < 0.05). In IGT subjects UCP3 protein increased in the intervention group (P = 0.02), while UCP3 remained unaltered in the control group (P = 0.64). Conclusion: Both, exercise training and a lifestyle‐intervention program increase UCP3 protein content in skeletal muscle of subjects with reduced glycaemic control, indicating a restoration towards normal UCP3 levels. These data support the idea that UCP3 has a role in the aetiology of type 2 diabetes mellitus.